Sort   by:  
 Page size 
UnknownClinical utility of plasma miR-371a-3p in germ cell tumors.
Not available
S-EPMC6349199 | biostudies-literature
UnknownEffects of primary granulocyte-colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors.
Not available
S-EPMC9353223 | biostudies-literature
UnknownLong-term sexual functioning in germ-cell tumor survivors.
Not available
S-EPMC7439516 | biostudies-literature
UnknownVitamin D and circulating tumor cells in primary breast cancer.
Not available
S-EPMC9489852 | biostudies-literature
UnknownLong-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors.
Not available
S-EPMC5947452 | biostudies-literature
UnknownPrognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.
Not available
S-EPMC5400624 | biostudies-literature
Unknownβcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors.
Not available
S-EPMC6215644 | biostudies-literature
UnknownPrognostic Value of Apoptosis-Inducing Factor (AIF) in Germ Cell Tumors.
Not available
S-EPMC7917670 | biostudies-literature
UnknownPaclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial.
Not available
S-EPMC8551461 | biostudies-literature
UnknownPrognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
Not available
S-EPMC4751222 | biostudies-literature
Sort   by:  
 Page size